Abstract
Introduction Adult migrants are at risk of under-immunisation and are likely to need catch-up vaccination to bring them in line with the UK schedule. The COVID-19 pandemic has highlighted and exacerbated inequities in vaccine uptake, with migrants facing additional barriers to information, low vaccine confidence, and access to vaccine services. There is a need for participatory and theory-based research that meaningfully engages underserved migrant groups to make sense of their experiences and beliefs about vaccination and uses these insights to co-produce tailored interventions which can increase uptake. COVID-19 vaccination provides a unique entry-point and opportunity to explore these issues in tandem with addressing routine immunisation gaps and developing more culturally-sensitive routine vaccination services.
Methods and analysis LISOLO MALAMU (‘Good Talk’) is a community-based participatory research study which uses co-design, design thinking and behaviour change theory to engage adult Congolese migrants in developing a tailored intervention to increase vaccine uptake. A community-academic coalition will lead and co-design the study. The study will involve i) in-depth interviews with adult Congolese migrants (foreign-born, >18 years), ii-iii) interviews and consensus workshops with clinical, public health and community stakeholders, and iv) co-design workshops with adult Congolese migrants. Qualitative data will be analysed iteratively, using Thematic Analysis, and mapped to the Theoretical Domains Framework, with participation from the coalition in discussing and interpreting findings and selecting intervention functions to guide the co-design workshops. Sociodemographic data of interview participants will be summarised using descriptive statistics. The study will run from approximately November 2021-November 2022.
Ethics and dissemination Ethics approval has been granted by the St George’s University Research Ethics Committee (REC reference 2021.0128). Study findings will be widely disseminated by the coalition through local community organisations in Hackney and broader academic and policy stakeholders, including a final celebration event. Recommendations for a future larger scale study and testing of prototyped interventions will be made.
Strengths
This study will directly respond to ongoing calls for community-centred and participatory approaches to engaging migrants in routine and COVID-19 vaccination, by implementing a value-driven and reciprocal approach to conducting a study addressing the needs of an underserved community.
The target population was selected following a comprehensive systematic review of the evidence (1) and pre-engagement scoping work conducted with migrant community representatives in London, UK. (2, 3)
It aims to co-produce a tailored intervention to address specific barriers to, and strengthen, vaccine uptake for COVID-19 and routine vaccines in adult Congolese migrants (including MMR, Td/IPV, and HPV) as set out by UKHSA guidance (4), and has been co-designed with, and will be co-delivered by, a coalition formed of academic researchers, a council for voluntary service (a local charity which offers services and support for local voluntary and community organisations), and a Congolese community-based organisation.
Limitations
As this study is tailored to the Congolese migrant population, other migrants who also face barriers to vaccine uptake are not included. Whilst we can draw some conclusions about the experiences of other Black migrants who face similar historical and cultural barriers to uptake of routine and COVID-19 vaccines, our ability to generalise the findings to all migrant communities might be limited.
Co-designed intervention prototypes will not be formally implemented and evaluated in this study, however recommendations will be made so that this can be done in a future phase.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Institute for Health Research (NIHR Advanced Fellowship 300072). SH and AFC are additionally funded by the Academy of Medical Sciences (SBF005 1111) and the World Health Organization. SH acknowledges funding from the Novo Nordisk Foundation La Caixa Foundation (Mobility Global Medicine and Health Research grant). The funders did not have any direct role in the writing or decision to submit this manuscript for publication. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics committee/IRB of St George's, University of London, gave ethical approval for this work (St George's University Research Ethics Committee, reference 2021.0128).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
acrawsha{at}sgul.ac.uk
caroline{at}hcvs.org.uk
hcwsg{at}outlook.com
hcwsg{at}outlook.com
hcwsg{at}outlook.com
fknights{at}sgul.ac.uk
yusufciftci4{at}gmail.com
lgoldsmi{at}sgul.ac.uk
t.vandrevala{at}sgul.kingston.ac.uk
alice.forman{at}ourfuturehealth.org.uk
Data Availability
The manuscript is a prospective study protocol and therefore does not contain data, however the data collected in future by the study will be available upon reasonable request to the authors.